Stay updated on Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.
Latest updates to the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check11 days agoChange DetectedThe website has updated the intervention type to 'Verified 2018-07 by Hamad Medical Corporation' and noted a status change to 'Not yet recruiting' with a revision to v2.14.0, while the previous intervention type and revision v2.13.3 have been removed.SummaryDifference0.7%
- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check47 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check62 days agoChange DetectedThe website has added new features for user interaction while removing detailed options for participant groups, interventions, and various data fields related to studies.SummaryDifference4%
- Check69 days agoChange DetectedSeveral links related to heart failure and Pioglitazone have been removed, including resources from MedlinePlus and PubMed.SummaryDifference1.0%
Stay in the know with updates to Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.